Benralizumab phase III trials show positive results in severe asthma – Press Release – AstraZeneca

Read first-hand Astra Zeneca’s press release where they report that AstraZeneca’s first biologic respiratory medicine met primary and key secondary endpoints in pivotal trials for severe asthma.

Source: Benralizumab phase III trials show positive results in severe asthma

This drug is potentially a breakthrough for severe asthma.

At the moment, the standard treatment is steroids. But systemic steroid exposure can lead to serious and irreversible adverse effects, including osteoporosis, anxiety, depression, weight gain, glaucoma and diabetes.

If you suffer with asthma or have a friend or family member with this condition, this article might give them new hope.

Thoughts?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: